[1] | US Centers for Disease Control and Prevention. The ABCs of Hepatitis. 2012. Professionals/PDFs/ABCTable_BW.pdf (accessed Nov 1, 2014). |
[2] | Beasley RP. Rocks along the road to the control of HBV and HCC. Ann Epidemiol 2009; 19: 231–34. |
[3] | Beasley R, Hwang L, Lin C, Chien C. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 1981; 2: 1129–33. |
[4] | Edmunds WJ, Medley GF, Nokes DJ, Hall AJ, Whittle HC. The influence of age on the development of the hepatitis B carrier state. Proc R Soc Lond B 1993; 253: 197–201. |
[5] | CDC. Update: recommendations to prevent hepatitis B Virus Transmission-United States. MMWR 1995; 44: 574–75. |
[6] | Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11: 97–107. |
[7] | GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 385: 117–71. |
[8] | Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015, published online June 7. http://dx.doi.org/10.1016/S0140-6736(15)60692-4. |
[9] | Lavanchy D: Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Virol Hepat. 2004, 11: 97-101. 10.1046/j.1365-2893.2003.00487. x. |
[10] | El-Zayadi A. Hepatitis B Virus Infection the Egyptian Situation. Arab J Gastroenterol 2007; 8: 94-98. |
[11] | Yu SJ, Kim YJ. Hepatitis B viral load affects prognosis of hepatocellular carcinoma. World J Gastroenterol 2014 Sep 14; 20(34): 12039–44. |
[12] | Sohn W, Paik YH, Cho JY, et al. Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load. J Viral Hepat 2015 Jun; 22(6): 539–50. |
[13] | Niitsuma H, Ishii M, Miura M, Kobayashi K, Toyota T. Low level hepatitis B viremia detected by polymerase chain reaction accompanies the absence of HBe antigenemia and hepatitis in hepatitis B virus carriers. Am J Gastroenterol 1997 Jan; 92(1): 119–23. |
[14] | Ranki M, Schätzl HM, Zachoval R, Uusi-Oukari M, Lehtovaara P. Quantification of hepatitis B virus DNA over a wide range from serum for studying viral replicative activity in response to treatment and in recurrent infection. Hepatology 1995 Jun; 21(6): 1492–9. |
[15] | Mason AL, Xu L, Guo L, Kuhns M, Perrillo RP. Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen. Hepatology 1998 Jun; 27(6): 1736–42. |
[16] | Saito T, Shinzawa H, Uchida T, Quantitative DNA analysis of low-level hepatitis B viremia in two patients with serologically negative chronic hepatitis B. J Med Virol 1999 Aug; 58(4): 325–31. |
[17] | Sohn W, Paik YH, Kim JM. HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBVrelated hepatocellular carcinoma. Ann Surg Oncol 2014 Jul; 21(7): 2429–35. |
[18] | Burbelo PD, Dubovi EJ, Simmonds P, et al. (June 2012). "Serology-enabled discovery of genetically diverse hepaciviruses in a new host". J. Virol. 86 (11): 6171–8. |
[19] | Shepard, CW; Finelli, L; Alter, MJ (Sep 2005). "Global epidemiology of hepatitis C virus infection.". Lancet Infect Dis. 5 (9): 558–67. doi:10.1016/S1473-3099(05)70216-4. PMID 16122679. |
[20] | Alter, MJ (Nov 2011). "HCV routes of transmission: what goes around comes around". Semin Liver Dis. 31 (4): 340–6. doi:10.1055/s-0031-1297923. PMID 22189974. |
[21] | Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012 Dec 15; 380(9859): 2095–128. |
[22] | Sievert W, Altraif I, Razavi H, et al. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int 2011; 31(Suppl 2): 61-80. |
[23] | Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001 Jul 5; 345(1): 41– 52. |
[24] | Lee MH, Yang HI, Yuan Y, L’Italien G, Chen CJ. Epidemiology and natural history of hepatitis C virus infection. World J Gastroenterol 2014 Jul 28; 20(28): 9270–80. |
[25] | Gervain J. The diagnosis of hepatitis C virus infection. Orv Hetil 2014 Jun 29; 155(26): 1019– 23. |
[26] | Butcher A, Aslam S, Hemyari P, Cowen U, Heilek G. HCV RNA detection in HCV antibodypositive patients with the COBAS AmpliPrep/COBAS TaqMan HCV test, v2.0 in comparison with FDA-approved nucleic acid tests. J Clin Virol 2014 Aug; 60(4): 336–40. |
[27] | Radkowski M, Opoka-Kegler J, Cortes KC, et al. Evidence for immune activation in patients with residual hepatitis C virus RNA long after successful treatment with IFN and ribavirin. J Gen Virol 2014 Sep; 95(Pt 9): 2004–9. |
[28] | Orito E, Mizokami M, Suzuki K, et al. Loss of serum HCV RNA at week 4 of interferon-alpha therapy is associated with more favorable longterm response in patients with chronic hepatitis C. J Med Virol 1995 Jun; 46(2): 109–15. |
[29] | Falasca K, Ucciferri C, Dalessandro M, et al. Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. Ann Clin Lab Sci 2006 Spring; 36(2): 144–50. |
[30] | Weiss RA (May 1993). "How does HIV cause AIDS?". Science. 260 (5112): 1273–9. Bibcode: 1993Sci...260.1273W. doi:10.1126/science.8493571. PMID 8493571. |
[31] | Douek DC, Roederer M, Koup RA (2009). "Emerging Concepts in the Immunopathogenesis of AIDS". Annu. Rev. Med. 60: 471–84. |
[32] | UNAIDS, WHO (December 2007). "2007 AIDS epidemic update" (PDF). p. 10. Retrieved 2008-03-12. |
[33] | Cunningham AL, Donaghy H, Harman AN, Kim M, Turville SG (2010). "Manipulation of dendritic cell function by viruses". Current opinion in microbiology. 13 (4): 524–529. doi: 10.1016/j.mib.2010.06.002. PMID 20598938. |
[34] | Doitsh, Gilad; Galloway, Nicole L. K.; Geng, Xin; Yang, Zhiyuan; Monroe, Kathryn M.; Zepeda, Orlando; Hunt, Peter W.; Hatano, Hiroyu; Sowinski, Stefanie; Muñoz-Arias, Isa; Greene, Warner C. (2014). "Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection.". Nature. 505 (7484): 509–514. doi:10.1038/nature12940. PMC 4047036free to read. PMID 24356306. |
[35] | Garg H, Mohl J, Joshi A (Nov 9, 2012). "HIV-1 induced bystander apoptosis". Viruses. 4 (11): 3020–43. doi:10.3390/v4113020. PMC 3509682free to read. PMID 23202514. |
[36] | Kumar, Vinay (2012). Robbins Basic Pathology (9th ed.). p. 147. ISBN 9781455737871. |
[37] | Roth WK, Busch MP, Schuller A, Ismay S, Cheng A, Seed CR, et al. International survey on NAT testing of blood donations: Expanding implementation and yield from 1999 to 2009. Vox Sang. 2012; 102: 82–90. |
[38] | Wiedmann M, Kluwick S, Walter M, Fauchald G, Howe J, Bronold M, et al. HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas TaqScreen MPX test in seroconverting donors. J Clin Virol. 2007; 39:282–7. |
[39] | Newman Dorland WA. Dorland's Illustrated Medical Dictionary, 28th edition. Philadelphia: WB Saunders Company. 1994. |
[40] | Mahmoud RA, El-Mazary AA, Khodeary A. Seroprevalence of Hepatitis C, Hepatitis B, Cytomegalovirus, and Human Immunodeficiency Viruses in Multitransfused Thalassemic Children in Upper Egypt. Adv Hematol. 2016; 2016: 9032627. |